254 related articles for article (PubMed ID: 19680263)
1. Monomeric CRP contributes to complement control in fluid phase and on cellular surfaces and increases phagocytosis by recruiting factor H.
Mihlan M; Stippa S; Józsi M; Zipfel PF
Cell Death Differ; 2009 Dec; 16(12):1630-40. PubMed ID: 19680263
[TBL] [Abstract][Full Text] [Related]
2. Monomeric C-reactive protein modulates classic complement activation on necrotic cells.
Mihlan M; Blom AM; Kupreishvili K; Lauer N; Stelzner K; Bergström F; Niessen HW; Zipfel PF
FASEB J; 2011 Dec; 25(12):4198-210. PubMed ID: 21856781
[TBL] [Abstract][Full Text] [Related]
3. Human complement factor H-related protein 4 binds and recruits native pentameric C-reactive protein to necrotic cells.
Mihlan M; Hebecker M; Dahse HM; Hälbich S; Huber-Lang M; Dahse R; Zipfel PF; Józsi M
Mol Immunol; 2009 Jan; 46(3):335-44. PubMed ID: 19084272
[TBL] [Abstract][Full Text] [Related]
4. Complement regulation at necrotic cell lesions is impaired by the age-related macular degeneration-associated factor-H His402 risk variant.
Lauer N; Mihlan M; Hartmann A; Schlötzer-Schrehardt U; Keilhauer C; Scholl HP; Charbel Issa P; Holz F; Weber BH; Skerka C; Zipfel PF
J Immunol; 2011 Oct; 187(8):4374-83. PubMed ID: 21930971
[TBL] [Abstract][Full Text] [Related]
5. Effect of modified C-reactive protein on complement activation: a possible complement regulatory role of modified or monomeric C-reactive protein in atherosclerotic lesions.
Ji SR; Wu Y; Potempa LA; Liang YH; Zhao J
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):935-41. PubMed ID: 16456095
[TBL] [Abstract][Full Text] [Related]
6. Sublytic complement attack exposes C-reactive protein binding sites on cell membranes.
Li YP; Mold C; Du Clos TW
J Immunol; 1994 Mar; 152(6):2995-3005. PubMed ID: 8144898
[TBL] [Abstract][Full Text] [Related]
7. Hemolytic uremic syndrome: a factor H mutation (E1172Stop) causes defective complement control at the surface of endothelial cells.
Heinen S; Józsi M; Hartmann A; Noris M; Remuzzi G; Skerka C; Zipfel PF
J Am Soc Nephrol; 2007 Feb; 18(2):506-14. PubMed ID: 17229916
[TBL] [Abstract][Full Text] [Related]
8. Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques.
Eisenhardt SU; Habersberger J; Murphy A; Chen YC; Woollard KJ; Bassler N; Qian H; von Zur Muhlen C; Hagemeyer CE; Ahrens I; Chin-Dusting J; Bobik A; Peter K
Circ Res; 2009 Jul; 105(2):128-37. PubMed ID: 19520972
[TBL] [Abstract][Full Text] [Related]
9. Factor H and atypical hemolytic uremic syndrome: mutations in the C-terminus cause structural changes and defective recognition functions.
Józsi M; Heinen S; Hartmann A; Ostrowicz CW; Hälbich S; Richter H; Kunert A; Licht C; Saunders RE; Perkins SJ; Zipfel PF; Skerka C
J Am Soc Nephrol; 2006 Jan; 17(1):170-7. PubMed ID: 16338962
[TBL] [Abstract][Full Text] [Related]
10. Studies on the interactions between C-reactive protein and complement proteins.
Bíró A; Rovó Z; Papp D; Cervenak L; Varga L; Füst G; Thielens NM; Arlaud GJ; Prohászka Z
Immunology; 2007 May; 121(1):40-50. PubMed ID: 17244159
[TBL] [Abstract][Full Text] [Related]
11. Interference of antimodified C-reactive protein autoantibodies from lupus nephritis in the biofunctions of modified C-reactive protein.
Yang XW; Tan Y; Yu F; Zhao MH
Hum Immunol; 2012 Feb; 73(2):156-63. PubMed ID: 22192784
[TBL] [Abstract][Full Text] [Related]
12. Native and modified C-reactive protein bind different receptors on human neutrophils.
Heuertz RM; Schneider GP; Potempa LA; Webster RO
Int J Biochem Cell Biol; 2005 Feb; 37(2):320-35. PubMed ID: 15474978
[TBL] [Abstract][Full Text] [Related]
13. Binding of C-reactive protein to the pneumococcal capsule or cell wall results in differential localization of C3 and stimulation of phagocytosis.
Holzer TJ; Edwards KM; Gewurz H; Mold C
J Immunol; 1984 Sep; 133(3):1424-30. PubMed ID: 6747291
[TBL] [Abstract][Full Text] [Related]
14. Comparison of surface recognition and C3b binding properties of mouse and human complement factor H.
Cheng ZZ; Hellwage J; Seeberger H; Zipfel PF; Meri S; Jokiranta TS
Mol Immunol; 2006 Mar; 43(7):972-9. PubMed ID: 16023208
[TBL] [Abstract][Full Text] [Related]
15. Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate: mCRP(m).
Ji SR; Wu Y; Zhu L; Potempa LA; Sheng FL; Lu W; Zhao J
FASEB J; 2007 Jan; 21(1):284-94. PubMed ID: 17116742
[TBL] [Abstract][Full Text] [Related]
16. Binding of C-reactive protein to nucleated cells leads to complement activation without cytolysis.
Berman S; Gewurz H; Mold C
J Immunol; 1986 Feb; 136(4):1354-9. PubMed ID: 3944459
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein and the acute phase response.
Gewurz H; Mold C; Siegel J; Fiedel B
Adv Intern Med; 1982; 27():345-72. PubMed ID: 7041546
[TBL] [Abstract][Full Text] [Related]
18. Complement factor H binding of monomeric C-reactive protein downregulates proinflammatory activity and is impaired with at risk polymorphic CFH variants.
Molins B; Fuentes-Prior P; Adán A; Antón R; Arostegui JI; Yagüe J; Dick AD
Sci Rep; 2016 Mar; 6():22889. PubMed ID: 26961257
[TBL] [Abstract][Full Text] [Related]
19. Binding of model soluble immune complexes to modified C-reactive protein.
Motie M; Brockmeier S; Potempa LA
J Immunol; 1996 Jun; 156(11):4435-41. PubMed ID: 8666818
[TBL] [Abstract][Full Text] [Related]
20. Streptococcus pneumoniae evades complement attack and opsonophagocytosis by expressing the pspC locus-encoded Hic protein that binds to short consensus repeats 8-11 of factor H.
Jarva H; Janulczyk R; Hellwage J; Zipfel PF; Björck L; Meri S
J Immunol; 2002 Feb; 168(4):1886-94. PubMed ID: 11823523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
